Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][unchecked revision]
Line 5: Line 5:
 
!Author Content (Pending or Complete)
 
!Author Content (Pending or Complete)
 
!Editor Reviewed (Date)
 
!Editor Reviewed (Date)
 +
!Notes
 
|-
 
|-
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
 +
|
 
|
 
|
 
|
 
|
Line 12: Line 14:
 
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
 
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 17: Line 20:
 
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
 
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 22: Line 26:
 
|    Polycythaemia Vera  (PV)||Disease
 
|    Polycythaemia Vera  (PV)||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 32:
 
|    Primary Myelofibrosis  (PMF)||Disease
 
|    Primary Myelofibrosis  (PMF)||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 32: Line 38:
 
|    Essential  Thrombocythaemia (ET)||Disease
 
|    Essential  Thrombocythaemia (ET)||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 37: Line 44:
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 42: Line 50:
 
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
 
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 51: Line 61:
 
|    Cutaneous  Mastocytosis||Disease
 
|    Cutaneous  Mastocytosis||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 56: Line 67:
 
|    Systemic Mastocytosis||Disease
 
|    Systemic Mastocytosis||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
Line 61: Line 73:
 
|    Mast Cell Sarcoma||Disease
 
|    Mast Cell Sarcoma||Disease
 
| ||FQR
 
| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease|| ||FQR
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease|| ||FQR
 
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease|| ||FQR
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Refractory Cytopenia  of Childhood||Disease|| ||FQR
 
|    Refractory Cytopenia  of Childhood||Disease|| ||FQR
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
Line 151: Line 185:
 
|Jennelle Hodge (JH)
 
|Jennelle Hodge (JH)
 
|Complete
 
|Complete
 +
|
 
|
 
|
 
|-
 
|-
−
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou ||JH
+
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
 
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
 
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
 
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
 
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou ||JH
+
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
 
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
 +
|
 
|
 
|
 
|
 
|
Line 184: Line 226:
 
|JH
 
|JH
 
|Complete
 
|Complete
 +
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
 
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
 
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
 
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
 
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
 
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
 
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
 
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
 
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
 
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
 
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
 
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
 
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
 
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
 
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
 
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
 
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
 
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
 
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
 
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
 
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
 
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
 
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
 
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
 
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
 
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
 
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
 
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
 
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
 
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
 
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
 
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
 
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH
 
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
 
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
 
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
 
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
 
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
 
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
 
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
 
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
 
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
 
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
 
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Splenic Marginal Zone Lymphoma||Disease|| ||SP
 
|Splenic Marginal Zone Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Hairy Cell Leukemia||Disease|| ||SP
 
|Hairy Cell Leukemia||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease|| ||SP
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Hairy Cell Leukemia  Variant||Disease|| ||SP
 
|    Hairy Cell Leukemia  Variant||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
 
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
 
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
 
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
 
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mu Heavy Chain  Disease||Disease|| ||SP
 
|    Mu Heavy Chain  Disease||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Gamma Heavy Chain  Disease||Disease|| ||SP
 
|   Gamma Heavy Chain  Disease||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Alpha Heavy Chain  Disease||Disease|| ||SP
 
|    Alpha Heavy Chain  Disease||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Plasma Cell Neoplasms||'''''Overview'''''|| ||SP
 
|Plasma Cell Neoplasms||'''''Overview'''''|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease|| ||SP
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Plasma Cell Myeloma||Disease|| ||SP
 
|    Plasma Cell Myeloma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Plasma Cell Myeloma  Variants||Disease|| ||SP
 
|    Plasma Cell Myeloma  Variants||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Plasmacytoma||Disease|| ||SP
 
|    Plasmacytoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
 
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|           Primary  Amyloidosis||Disease|| ||SP
 
|           Primary  Amyloidosis||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
 
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
 
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|         POEMS Syndrome||Disease|| ||SP
 
|         POEMS Syndrome||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|         TEMPI Syndrome||Disease|| ||SP
 
|         TEMPI Syndrome||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||SP
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
 
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
 
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Follicular Lymphoma||Disease|| ||SP
 
|Follicular Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Testicular Follicular  Lymphoma||Disease|| ||SP
 
|    Testicular Follicular  Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    In Situ Follicular  Neoplasia||Disease|| ||SP
 
|    In Situ Follicular  Neoplasia||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
 
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
 
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
 
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
 
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Mantle Cell Lymphoma||Disease|| ||SP
 
|Mantle Cell Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||SP
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    In Situ Mantle Cell  Neoplasia||Disease|| ||SP
 
|    In Situ Mantle Cell  Neoplasia||Disease|| ||SP
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
 
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
 
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
 
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
 
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
 
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
 
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
 
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Lymphomatoid Granulomatosis||Disease|| ||GC
 
|Lymphomatoid Granulomatosis||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
 
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
 
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
 
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Plasmablastic Lymphoma||Disease|| ||GC
 
|Plasmablastic Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Effusion Lymphoma||Disease|| ||GC
 
|Primary Effusion Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
 
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Multicentric Castleman  Disease||Disease|| ||GC
 
|   Multicentric Castleman  Disease||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
 
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Burkitt Lymphoma||Disease|| ||GC
 
|Burkitt Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
 
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
 
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
 
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
 
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Associate Editor??
 
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Associate Editor??
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|T-cell Prolymphocytic Leukemia||Disease|| ||
 
|T-cell Prolymphocytic Leukemia||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|T-cell Large Granular Lymphocytic Leukemia||Disease|| ||
 
|T-cell Large Granular Lymphocytic Leukemia||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease|| ||
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Aggressive NK-cell Leukemia||Disease|| ||
 
|Aggressive NK-cell Leukemia||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||
 
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||
 
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||
 
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||
 
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Severe Mosquito Bite  Allergy||Disease|| ||
 
|    Severe Mosquito Bite  Allergy||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Adult T-cell Leukemia/Lymphoma||Disease|| ||
 
|Adult T-cell Leukemia/Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||
 
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||
 
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease|| ||
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Hepatosplenic T-cell Lymphoma||Disease|| ||
 
|Hepatosplenic T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||
 
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Mycosis Fungoides||Disease|| ||
 
|Mycosis Fungoides||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Sézary Syndrome||Disease|| ||
 
|Sézary Syndrome||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||
 
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Lymphomatoid  Papulosis||Disease|| ||
 
|    Lymphomatoid  Papulosis||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||
 
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||
 
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||
 
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||
 
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||
 
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||
 
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
 
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||
 
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Follicular T-cell  Lymphoma||Disease|| ||
 
|    Follicular T-cell  Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||
 
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| ||
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| ||
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| ||
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
 
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
 
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
 
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
 
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
 
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
 
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
 
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Lymphomas Associated with HIV Infection||Disease|| ||
 
|Lymphomas Associated with HIV Infection||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
 
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|          Monomorphic  B-cell PTLD||Disease|| ||
 
|          Monomorphic  B-cell PTLD||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
 
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
 
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
 
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
 
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Histiocytic Sarcoma||Disease|| ||
 
|Histiocytic Sarcoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
 
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Langerhans Cell  Histiocytosis||Disease|| ||
 
|   Langerhans Cell  Histiocytosis||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Langerhans Cell  Sarcoma||Disease|| ||
 
|   Langerhans Cell  Sarcoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Indeterminate Dendritic Cell Tumour||Disease|| ||
 
|Indeterminate Dendritic Cell Tumour||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
 
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Follicular Dendritic Cell Sarcoma||Disease|| ||
 
|Follicular Dendritic Cell Sarcoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
 
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Fibroblastic Reticular Cell Tumor||Disease|| ||
 
|Fibroblastic Reticular Cell Tumor||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
 
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Erdheim-Chester Disease||Disease|| ||
 
|Erdheim-Chester Disease||Disease|| ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || || ||
 
| || || ||
 +
|
 
|
 
|
 
|
 
|
 
|}
 
|}

Revision as of 18:08, 21 May 2020

Disease Page Type Author Associate Editor Author Content (Pending or Complete) Editor Reviewed (Date) Notes
Myeloproliferative Neoplasms (MPN) Overview Fabiola Quintero-Rivera (FQR)
    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive Disease FQR
    Chronic Neutrophilic Leukemia (CNL) Disease FQR
    Polycythaemia Vera (PV) Disease FQR
    Primary Myelofibrosis (PMF) Disease FQR
    Essential Thrombocythaemia (ET) Disease FQR
    Chronic Eosinophilic Leukemia, Not Otherwise Specified Disease FQR
    Myeloproliferative Neoplasm (MPN), Unclassifiable Disease FQR
Mastocytosis Overview FQR
    Cutaneous Mastocytosis Disease FQR
    Systemic Mastocytosis Disease FQR
    Mast Cell Sarcoma Disease FQR
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 Overview FQR
    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Disease FQR
    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Disease FQR
    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Disease FQR
    Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Disease FQR
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Overview FQR
    Chronic Myelomonocytic Leukemia (CMML) Disease FQR
    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Disease FQR
    Juvenile Myelomonocytic Leukemia (JMML) Disease FQR
    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Disease FQR
    Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Disease FQR
Myelodysplastic Syndromes (MDS) Overview FQR
    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia Disease FQR
    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) Disease FQR
    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia Disease FQR
    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia Disease FQR
    Myelodysplastic Syndrome (MDS) with Excess Blasts Disease FQR
    Myelodysplastic Syndrome (MDS) with Isolated del(5q) Disease FQR
    Myelodysplastic Syndrome (MDS), Unclassifiable Disease FQR
    Refractory Cytopenia of Childhood Disease FQR
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms Overview Daynna Wolff+Path Resident Jennelle Hodge (JH) Complete
Myeloid Neoplasms with Germline Predisposition Overview Ying Zou JH
    Acute Myeloid Leukaemia with Germline CEBPA Mutation Disease Daynna Wolff+Path Resident JH
    Myeloid Neoplasms with Germline DDX41 Mutation Disease Fei Yang JH
    Myeloid Neoplasms with Germline RUNX1 Mutation Disease Malini Sathanoori JH
    Myeloid Neoplasms with Germline ANKRD26 Mutation Disease Fei Yang JH
    Myeloid Neoplasms with Germline ETV6 Mutation Disease Ying Zou JH
    Myeloid Neoplasms with Germline GATA2 Mutation Disease Daynna Wolff+Path Resident JH
Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Overview Daynna Wolff+Path Resident JH Complete
    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Disease Christine Bryke JH
    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Disease Christine Bryke JH
    Acute Promyelocytic Leukemia (APL) with PML-RARA Disease Shashi Shetty JH
    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Disease Shashi Shetty JH
    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Disease Jennelle Hodge JH
    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Disease Gordana Raca JH
    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Disease Jennelle Hodge JH
    Acute Myeloid Leukemia (AML) with BCR-ABL1 Disease Kay Weng Choy via Greg Conboy (Monash Health) JH
    Acute Myeloid Leukemia (AML) with Mutated NPM1 Disease Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health) JH
    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Disease Paul deFazio, MSc, via Greg Conboy (Monash Health) JH
    Acute Myeloid Leukemia (AML) with Mutated RUNX1 Disease Daynna Wolff+Path Resident (Iris Martin) JH
Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Disease Fei Yang JH
Therapy-Related Myeloid Neoplasms Disease Shashi Shetty + resident JH
Acute Myeloid Leukemia (AML), Not Otherwise Specified Overview Anwar Iqbal JH
    Acute Myeloid Leukemia (AML) with Minimal Differentiation Disease Fabiola Quintero-Rivera JH
   Acute Myeloid Leukemia (AML) without Maturation Disease Jennelle Hodge JH
    Acute Myeloid Leukemia (AML) with Maturation Disease Jennelle Hodge JH
    Acute Myelomonocytic Leukemia Disease Fei Yang JH
    Acute Monoblastic and Monocytic Leukemia Disease Fei Yang JH
    Pure Erythroid Leukemia Disease Ash Yenamandra JH
    Acute Megakaryoblastic Leukemia (AMKL) Disease Fei Yang JH
    Acute Basophilic Leukemia Disease Ash Yenamandra JH
    Acute Panmyelosis with Myelofibrosis Disease Ying Zou and Jialing Huang JH
Myeloid Sarcoma Disease Fabiola Quintero-Rivera JH
Myeloid Proliferations Associated with Down Syndrome Overview Patty Greipp JH
    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome Disease Linda Cooley JH
    Myeloid Leukemia Associated with Down Syndrome Disease Linda Cooley JH
Blastic Plasmacytoid Dendritic Cell Neoplasm Disease Daynna Wolff+Path Resident JH
Acute Leukemias of Ambiguous Lineage Overview Hui Chen/ Jennelle Hodge JH
    Acute Undifferentiated Leukemia Disease Shashi Shetty + resident JH
    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 Disease Tracy Tucker JH
    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged Disease Tracy Tucker JH
    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified Disease Shashi Shetty + resident JH
    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified Disease Fabiola Quintero-Rivera JH
    ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types Disease JH
    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS) Disease JH
Precursor Lymphoid Neoplasms Overview Yassmine Akkari (YA)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Overview YA
    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with iAMP21 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified Disease YA
T-Lymphoblastic Leukemia/Lymphoma Overview YA
Early T-Cell Precursor Lymphoblastic Leukemia Disease YA
NK-Lymphoblastic Leukemia/Lymphoma Disease YA
Mature B-Cell Neoplasms Overview Snehal Patel (SP)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Disease SP
       Monoclonal B-cell Lymphocytosis Disease SP
B-cell Prolymphocytic Leukemia Disease SP
Splenic Marginal Zone Lymphoma Disease SP
Hairy Cell Leukemia Disease SP
Splenic B-cell Lymphoma/Leukemia, Unclassifiable Overview SP
    Splenic Diffuse Red Pulp Small B-cell Lymphoma Disease SP
    Hairy Cell Leukemia Variant Disease SP
Lymphoplasmacytic Lymphoma Disease SP
   Waldenstrom Macroglobulinemia Disease SP
IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
Heavy Chain Diseases Overview SP
    Mu Heavy Chain Disease Disease SP
   Gamma Heavy Chain Disease Disease SP
    Alpha Heavy Chain Disease Disease SP
Plasma Cell Neoplasms Overview SP
   Non-IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
    Plasma Cell Myeloma Disease SP
    Plasma Cell Myeloma Variants Disease SP
    Plasmacytoma Disease SP
    Monoclonal Immunoglobulin Deposition Diseases Overview SP
           Primary Amyloidosis Disease SP
           Light Chain and Heavy Chain Deposition Disease Disease SP
Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome Overview SP
         POEMS Syndrome Disease SP
         TEMPI Syndrome Disease SP
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Disease SP
Nodal Marginal Zone Lymphoma Disease SP
    Paediatric Nodal Marginal Zone Lymphoma Disease SP
Follicular Lymphoma Disease SP
    Testicular Follicular Lymphoma Disease SP
    In Situ Follicular Neoplasia Disease SP
    Duodenal-Type Follicular Lymphoma Disease SP
Paediatric-Type Follicular Lymphoma Disease SP
Large B-cell Lymphoma with IRF4 Rearrangement Disease SP
Primary Cutaneous Follicle Centre Lymphoma Disease SP
Mantle Cell Lymphoma Disease SP
    Leukemic Non-Nodal Mantle Cell Lymphoma Disease SP
    In Situ Mantle Cell Neoplasia Disease SP
Diffuse Large B-cell Lymphoma, Not Otherwise Specified Disease Greg Corboy (GC)
T-cell/Histiocyte-Rich Large B-cell Lymphoma Disease GC
Primary Diffuse Large B-cell Lymphoma of the CNS Disease GC
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type Disease GC
EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
EBV-Positive Mucocutaneous Ulcer Disease GC
Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation Disease GC
    Fibrin-Associated Diffuse Large B-cell Lymphoma Disease GC
Lymphomatoid Granulomatosis Disease GC
Primary Mediastinal (Thymic) Large B-cell Lymphoma Disease GC
Intravascular Large B-cell Lymphoma Disease GC
ALK-Positive Large B-cell Lymphoma Disease GC
Plasmablastic Lymphoma Disease GC
Primary Effusion Lymphoma Disease GC
HHV8-Associated Lymphoproliferative Disorders Overview GC
   Multicentric Castleman Disease Disease GC
   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
   HHV8-Positive Germinotropic Lymphoproliferative Disorder Disease GC
Burkitt Lymphoma Disease GC
Burkitt-Like Lymphoma with 11q Aberration Disease GC
High-Grade B-cell Lymphoma Overview GC
    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Disease GC
    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma Disease GC
Mature T- and NK-cell Neoplasms Overview Associate Editor??
T-cell Prolymphocytic Leukemia Disease
T-cell Large Granular Lymphocytic Leukemia Disease
Chronic Lymphoproliferative Disorder of NK Cells Disease
Aggressive NK-cell Leukemia Disease
EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood Overview
  Systemic EBV-Positive T-cell Lymphoma of Childhood Disease
   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form Disease
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder Disease
    Severe Mosquito Bite Allergy Disease
Adult T-cell Leukemia/Lymphoma Disease
Extranodal NK/T-cell Lymphoma, Nasal Type Disease
Intestinal T-cell Lymphoma Overview
    Enteropathy-Associated T-cell Lymphoma Disease
     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Disease
     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) Disease
    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Disease
Hepatosplenic T-cell Lymphoma Disease
Subcutaneous Panniculitis-Like T-cell Lymphoma Disease
Mycosis Fungoides Disease
Sézary Syndrome Disease
Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders Overview
    Lymphomatoid Papulosis Disease
    Primary Cutaneous Anaplastic Large Cell Lymphoma Disease
Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes Overview
     Primary Cutaneous Gamma Delta T-cell Lymphoma Disease
     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Disease
     Primary Cutaneous Acral CD8+ T-cell Lymphoma Disease
     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder Disease
Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) Disease
Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin Overview
     Angioimmunoblastic T-cell Lymphoma Disease
    Follicular T-cell Lymphoma Disease
     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype Disease
Anaplastic Large Cell Lymphoma, ALK-Positive Disease
Anaplastic Large Cell Lymphoma, ALK-Negative Disease
Breast Implant-Associated Anaplastic Large Cell Lymphoma Disease
Hodgkin Lymphomas Overview Associate Editor??
Nodular Lymphocyte Predominant Hodgkin Lymphoma Disease
Classic Hodgkin Lymphoma Overview
    Nodular Sclerosis Classic Hodgkin Lymphoma Disease
    Lymphocyte-Rich Classic Hodgkin Lymphoma Disease
    Mixed Cellularity Classic Hodgkin Lymphoma Disease
    Lymphocyte-Depleted Classic Hodgkin Lymphoma Disease
Immunodeficiency-Associated Lymphoproliferative Disorders Overview
Lymphomas Associated with HIV Infection Disease
Post-Transplant Lymphoproliferative Disorders Overview
    Non-Destructive Post-Transplant Lymphoproliferative Disorders Disease
    Polymorphic Post-Transplant Lymphoproliferative Disorders Disease
    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) Overview
          Monomorphic B-cell PTLD Disease
          Monomorphic T/NK-cell PTLD Disease
    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Disease
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Disease
Histiocytic and Dendritic Cell Neoplasms Overview
Histiocytic Sarcoma Disease
Tumors Derived From Langerhans Cells Overview
   Langerhans Cell Histiocytosis Disease
   Langerhans Cell Sarcoma Disease
Indeterminate Dendritic Cell Tumour Disease
Interdigitating Dendritic Cell Sarcoma Disease
Follicular Dendritic Cell Sarcoma Disease
    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma Disease
Fibroblastic Reticular Cell Tumor Disease
Disseminated Juvenile Xanthogranuloma Disease
Erdheim-Chester Disease Disease
Retrieved from "https://ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=7934"